28355-23-9Relevant academic research and scientific papers
SUBSTITUTED 1,2,4-OXADIAZOLES AND ANALOGS THEREOF AS CB2 RECEPTOR MODULATORS, USEFUL IN THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES
-
Page/Page column 25-26, (2009/05/28)
The present invention relates to compounds represented by Formula (I), Formula (II) and Formula (III) and pharmaceutically acceptable salts thereof. The present invention also provides pharmaceutical compositions comprising the instant compounds. This inv
BONE METABOLISM IMPROVING AGENTS
-
, (2008/06/13)
Compounds of general formula (I): wherein R1, R2, R3, R4, X, Y and A have the meanings given herein which are useful in the curative and prophylactic treatment of a medical condition for which inhibition of a cyclic guanosine 3',5'-monophosphate phosphodiesterase (e.g. cGMP PDE5) is desired.
Pharmaceutically active compounds
-
, (2008/06/13)
There is provided compounds of formula I, wherein R1, R2, R3and Het1have meanings given in the description, which are useful in the curative and prophylactic treatment of medical conditions for which inhibition of a cyclic guanosine 3′,5′-monophosphate phosphodiesterase (e.g. cGMP PDE5) is desired.
Pharmaceutically active compounds
-
, (2008/06/13)
There is provided compounds of formula IA and of formula IB, wherein R1, R2, R3, Het1and X have meanings given in the description, which are useful in the curative and prophylactic treatment of medical condition
Pharmaceutically active compounds
-
, (2008/06/13)
Compounds of general formula (I): wherein R1, R2, R3, R4, X, Y and A have the meanings given herein which are useful in the curative and prophylactic treatment of a medical condition for which inhibition of a cyclic guanosine 3′,5′-monophosphate phosphodiesterase (e.g. cGMP PDE5) is desired.
